亚洲在线日韩伦理片,96精品国产AⅤ一区二区,青鸟影视网,yy黄色频道,国内精品久久久精品AV电影院

Latest News

Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth

 BEIJING, SHANGHAI and BOSTON, Sept. 25, 2025 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK)today...

2025-09-26 08:47 709

Jacobio Pharma Announces 2025 Interim Results

 BEIJING and SHANGHAI and BOSTON, Aug. 29, 2025 /PRNewswire/ --?Jacobio Pharma (1167.HK) today annou...

2025-08-30 00:25 4670

Jacobio Pharma Announces 2024 Annual Results

 BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) released its ...

2025-03-19 21:42 3293

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

 BEIJING, SHANGHAI and BOSTON, Jan. 6, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-sta...

2025-01-07 08:30 1577

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

 BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-sta...

2024-12-09 08:42 1645

Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China

 BEIJING and SHANGHAI and BOSTON, Aug. 30, 2024 /PRNewswire/ --?Jacobio Pharma (1167.HK), a clinical...

2024-08-30 19:34 6303

Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO

 BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical...

2024-06-02 08:25 4228

Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint

 BEIJING and SHANGHAI and BOSTON, April 30, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced ...

2024-05-01 08:59 2037

Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting

 BEIJING, SHANGHAI, and SAN DIEGO, April 9, 2024 /PRNewswire/ -- Jacobin Pharma (1167.HK), a clinica...

2024-04-09 19:59 1980

Jacobio Pharma Announces 2023 Annual Results

 BEIJING, SHANGHAI and BOSTON, March 28, 2024 Jacobio/PRNewswire/ --? Pharma (1167.HK), a clinical-s...

2024-03-29 08:50 5020

Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S.

 BEIJING, SHANGHAI and BOSTON, March 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-st...

2024-03-01 14:55 2853

Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor

 BEIJING and?SHANGHAI and BOSTON, Feb. 18, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical...

2024-02-18 20:50 2984

Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI

 BEIJING and SAN FRANCISCO, Jan. 19, 2024 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK), a clini...

2024-01-20 06:30 3160

Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO

 * The ORR (objective response rate) and the DCR (disease control rate) in the frontline setting o...

2023-10-22 15:05 2495

Jacobio Pharma Announces 2023 Interim Results

 BEIJING, SHANGHAI and BOSTON, Aug. 30, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-st...

2023-08-30 21:45 4299

Jacobio Pharma Announces Breakthrough Therapy Designation from China CDE for KRAS G12C Inhibitor Glecirasib for the Treatment of Pancreatic Cancer

 BEIJING, SHANGHAI and BOSTON, Aug. 7, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-sta...

2023-08-07 20:03 2514

Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference

 BEIJING and SHANGHAI and BOSTON, July 20, 2023 /PRNewswire/ --?Jacobio Pharma (1167.HK), a clinical...

2023-07-21 10:19 2199

Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China

 BEIJING, SHANGHAI and BOSTON, July 4, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-sta...

2023-07-04 21:16 2704

Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer

 BEIJING, KYOTO and BOSTON, June 29, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage...

2023-06-29 16:31 2215

Jacobio Pharma Announces 2022 Annual Results

 BEIJING,?SHANGHAI?and?BOSTON, March 22, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced its...

2023-03-22 22:38 3542
123